Herbert J. Conrad
Director, Savient Pharmaceuticals.
Companies
- Celldex TherapeuticsBoard member Mar 17, 2008 to now1
- Matinas BioPharma Holdings, Inc.Board member Mar 1, 2017 to Nov 3, 20232
- Arbutus BiopharmaBoard member Mar 16, 2015 to Jun 22, 20183
- Savient PharmaceuticalsBoard member Jan 3, 2006 to Jun 10, 20104
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Matinas BioPharma Holdings, Inc. MTNB4,694,566 shares5$11.4M at $2.42Jun 22, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 22, 2022Gift 1,358,122 shares of Matinas BioPharma Holdings, Inc.5
- Jun 22, 2022Gift 1,358,122 shares of Matinas BioPharma Holdings, Inc.5
- Aug 4, 2021Gift 494,622 shares of Matinas BioPharma Holdings, Inc.5
- Aug 4, 2021Gift 494,622 shares of Matinas BioPharma Holdings, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCelldex Therapeutics, Board member
- 2
- 3SEC EDGARArbutus Biopharma, Board member
- 4
- 5